The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178, 7640 -7648
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casey, K. A.
Right arrow Articles by Mescher, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casey, K. A.
Right arrow Articles by Mescher, M. F.

IL-21 Promotes Differentiation of Naive CD8 T Cells to a Unique Effector Phenotype1

Kerry A. Casey and Matthew F. Mescher2

Center for Immunology, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455

IL-21, the most recently described member of the common {gamma}-chain cytokine family, is produced by activated CD4 T cells, whereas CD8 T cells express the IL-21 receptor. To investigate a possible role for IL-21 in the priming of naive CD8 T cells, we examined responses of highly purified naive OT-I CD8 T cells to artificial APCs displaying Ag and B7-1 on their surface. We found that IL-21 enhanced OT-I clonal expansion and supported development of cytotoxic effector function. High levels of IL-2 did not support development of effector functions, but IL-2 was required for optimal responses in the presence of IL-21. IL-12 and IFN-{alpha} have previously been shown to support naive CD8 T cell differentiation and acquisition of effector functions through a STAT4-dependent mechanism. Here, we show that IL-21 does not require STAT4 to stimulate development of cytolytic activity. Furthermore, IL-21 fails to induce IFN-{gamma} or IL-4 production and can partially block IL-12 induction of IFN-{gamma} production. CD8 T cells that differentiate in response to IL-21 have a distinct surface marker expression pattern and are characterized as CD44high, PD-1low, CD25low, CD134low, and CD137low. Thus, IL-21 can provide a signal required by naive CD8 T cells to differentiate in response to Ag and costimulation, and the resulting effector cells represent a unique effector phenotype with highly effective cytolytic activity, but deficient capacity to secrete IFN-{gamma}.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants CA82596 and A134824.

2 Address correspondence and reprint requests to Dr. Matthew F. Mescher, Center for Immunology, Box 334 Mayo, 420 Delaware Street SE, Minneapolis, MN 55455. E-mail address: mesch001{at}umn.edu

3 Abbreviations used in this paper: DC, dendritic cell; aAPC, artificial APC; {gamma}c, common {gamma}-chain.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. E. Hogg, G. C. Bowick, N. K. Herzog, M. W. Cloyd, and J. J. Endsley
Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1
J. Leukoc. Biol., November 1, 2009; 86(5): 1191 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Agarwal, A. Raghavan, S. L. Nandiwada, J. M. Curtsinger, P. R. Bohjanen, D. L. Mueller, and M. F. Mescher
Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory
J. Immunol., August 1, 2009; 183(3): 1695 - 1704.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Curtis, S. S. Way, and C. B. Wilson
IL-23 Promotes the Production of IL-17 by Antigen-Specific CD8 T Cells in the Absence of IL-12 and Type-I Interferons
J. Immunol., July 1, 2009; 183(1): 381 - 387.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. D. S. Johnson and S. C. Jameson
A Chronic Need for IL-21
Science, June 19, 2009; 324(5934): 1525 - 1526.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. J. Ramos, A. M. Davis, A. G. Cole, J. D. Schatzle, J. Forman, and J. D. Farrar
Reciprocal responsiveness to interleukin-12 and interferon-{alpha} specifies human CD8+ effector versus central memory T-cell fates
Blood, May 28, 2009; 113(22): 5516 - 5525.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Thedrez, C. Harly, A. Morice, S. Salot, M. Bonneville, and E. Scotet
IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V{gamma}9V{delta}2 T Cells for Adoptive Immunotherapy
J. Immunol., March 15, 2009; 182(6): 3423 - 3431.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Hamada, M. d. l. L. Garcia-Hernandez, J. B. Reome, S. K. Misra, T. M. Strutt, K. K. McKinstry, A. M. Cooper, S. L. Swain, and R. W. Dutton
Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
J. Immunol., March 15, 2009; 182(6): 3469 - 3481.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Xiao, K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F. Mescher
Programming for CD8 T Cell Memory Development Requires IL-12 or Type I IFN
J. Immunol., March 1, 2009; 182(5): 2786 - 2794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Acosta-Iborra, A. Elorza, I. M. Olazabal, N. B. Martin-Cofreces, S. Martin-Puig, M. Miro, M. J. Calzada, J. Aragones, F. Sanchez-Madrid, and M. O. Landazuri
Macrophage Oxygen Sensing Modulates Antigen Presentation and Phagocytic Functions Involving IFN-{gamma} Production through the HIF-1{alpha} Transcription Factor
J. Immunol., March 1, 2009; 182(5): 3155 - 3164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Zhang, J. Rowe, M. Kusel, A. Bosco, K. McKenna, N. de Klerk, P. D. Sly, and P. G. Holt
Interleukin-10/Interleukin-5 Responses at Birth Predict Risk for Respiratory Infections in Children with Atopic Family History
Am. J. Respir. Crit. Care Med., February 1, 2009; 179(3): 205 - 211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Y. Gerner, K. A. Casey, and M. F. Mescher
Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses
J. Immunol., July 1, 2008; 181(1): 155 - 164.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. Hinrichs, R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Blood, June 1, 2008; 111(11): 5326 - 5333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Usharauli and T. Kamala
Brief Antigenic Stimulation Generates Effector CD8 T Cells with Low Cytotoxic Activity and High IL-2 Production
J. Immunol., April 1, 2008; 180(7): 4507 - 4513.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. N. Orgun, M. A. Mathis, C. B. Wilson, and S. S. Way
Deviation from a Strong Th1-Dominated to a Modest Th17-Dominated CD4 T Cell Response in the Absence of IL-12p40 and Type I IFNs Sustains Protective CD8 T Cells
J. Immunol., March 15, 2008; 180(6): 4109 - 4115.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
I. M. Olazabal, N. B. Martin-Cofreces, M. Mittelbrunn, G. Martinez del Hoyo, B. Alarcon, and F. Sanchez-Madrid
Activation Outcomes Induced in Naive CD8 T-Cells by Macrophages Primed via "Phagocytic" and Nonphagocytic Pathways
Mol. Biol. Cell, February 1, 2008; 19(2): 701 - 710.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.